• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国大陆汉族人群中 ATP13A2 Ala746Thr 变异与帕金森病之间缺乏关联。

Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.

机构信息

Department of Neurology and Institute of Neurology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

Neurosci Lett. 2010 May 14;475(2):61-3. doi: 10.1016/j.neulet.2010.03.018. Epub 2010 Mar 19.

DOI:10.1016/j.neulet.2010.03.018
PMID:20227461
Abstract

ATP13A2 (PARK9) mutations are related to Kufor-Rakeb syndrome (KRS). We performed genetic analysis of the Ala746Thr variant in an independent cohort of the patients with PD and healthy controls from mainland China. The Ala746Thr variant was present in 1/532 (0.19%) of PD compared with 1/480 (0.21%) of healthy controls (odds ratio=0.90, 95% CI 0.06, 14.39, P=1.00). The two subjects carried the heterozygous genotype. Subset analysis in the group </=50 years of age revealed a prevalence of 0.7% in PD compared with 0% in healthy controls and in the group >50 years of age showed 0% in PD versus 0.3% in healthy controls. We did not observe a significant association between Ala746Thr and Parkinson's disease in Han Chinese population, even after stratification by age at onset. The results suggested that Ala746Thr variant was not a major susceptible factor for PD in Han Chinese people.

摘要

ATP13A2(PARK9)突变与 Kufor-Rakeb 综合征(KRS)有关。我们对来自中国大陆的 PD 患者和健康对照组的独立队列进行了 Ala746Thr 变体的遗传分析。与 480 名健康对照者中的 1 名(2.1%)相比,PD 患者中有 1 名(0.19%)携带 Ala746Thr 变体(比值比=0.90,95%CI 0.06,14.39,P=1.00)。这两个个体携带杂合基因型。年龄 </=50 岁的亚组分析显示,PD 的患病率为 0.7%,而健康对照组为 0%;年龄>50 岁的亚组分析显示,PD 的患病率为 0%,而健康对照组为 0.3%。即使按发病年龄分层,我们也未观察到 Ala746Thr 与汉族人群帕金森病之间存在显著关联。结果表明,Ala746Thr 变体不是汉族人群 PD 的主要易感因素。

相似文献

1
Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.中国大陆汉族人群中 ATP13A2 Ala746Thr 变异与帕金森病之间缺乏关联。
Neurosci Lett. 2010 May 14;475(2):61-3. doi: 10.1016/j.neulet.2010.03.018. Epub 2010 Mar 19.
2
The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.ATP13A2 基因 Ala746Thr 变异在中国帕金森病患者中的作用。
J Clin Neurosci. 2013 May;20(5):761-2. doi: 10.1016/j.jocn.2012.05.052. Epub 2013 Mar 20.
3
ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.新疆帕金森病患者的 ATP13A2 基因突变。
Biomed Res Int. 2020 Nov 30;2020:6954820. doi: 10.1155/2020/6954820. eCollection 2020.
4
Analysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.新疆维吾尔族和汉族帕金森病患者ATP13A2基因Thr12Met和Ala1144Thr突变分析
Med Sci Monit. 2014 Nov 6;20:2177-82. doi: 10.12659/MSM.892821.
5
Rapid screening of ATP13A2 variant with high-resolution melting analysis.应用高分辨率熔解曲线分析快速筛查 ATP13A2 变异体。
Mov Disord. 2010 Oct 30;25(14):2434-7. doi: 10.1002/mds.23106.
6
Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore.在台湾和新加坡发现的与帕金森病相关的新型ATP13A2变体。
Neurology. 2008 Nov 18;71(21):1727-32. doi: 10.1212/01.wnl.0000335167.72412.68.
7
Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis.ATP13A2基因A746T变异与中国汉族人群帕金森病易感性之间无关联:一项荟萃分析。
Int J Neurosci. 2016;126(7):593-9. doi: 10.3109/00207454.2015.1035377. Epub 2015 Jun 5.
8
Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.ATP13A2基因变异与帕金森综合征:一项初步综述。
Biomed Res Int. 2014;2014:371256. doi: 10.1155/2014/371256. Epub 2014 Aug 14.
9
Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation.Kufor-Rakeb 综合征/帕金森病 9 型:一种新发现的和一种可能反复出现的阿什肯纳兹族人群 ATP13A2 突变。
J Parkinsons Dis. 2018;8(3):399-403. doi: 10.3233/JPD-181360.
10
ATP13A2 variants in early-onset Parkinson's disease patients and controls.ATP13A2 变异与早发性帕金森病患者及对照。
Mov Disord. 2009 Oct 30;24(14):2104-11. doi: 10.1002/mds.22728.

引用本文的文献

1
ATP13A2 (PARK9) and basal ganglia function.ATP13A2(PARK9)与基底神经节功能。
Front Neurol. 2024 Jan 5;14:1252400. doi: 10.3389/fneur.2023.1252400. eCollection 2023.
2
ATP13A2 Gene Variants in Patients with Parkinson's Disease in Xinjiang.新疆帕金森病患者的 ATP13A2 基因突变。
Biomed Res Int. 2020 Nov 30;2020:6954820. doi: 10.1155/2020/6954820. eCollection 2020.
3
The Emerging Role of the Lysosome in Parkinson's Disease.溶酶体在帕金森病中的新兴作用。
Cells. 2020 Nov 2;9(11):2399. doi: 10.3390/cells9112399.
4
Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.儿科溶酶体贮积症与成人帕金森病之间新出现的联系。
Mov Disord. 2019 May;34(5):614-624. doi: 10.1002/mds.27631. Epub 2019 Feb 6.
5
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).ATP13A2/PARK9基因的功能丧失突变会导致复杂型遗传性痉挛性截瘫(SPG78)。
Brain. 2017 Feb;140(2):287-305. doi: 10.1093/brain/aww307.
6
Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.ATP13A2基因变异与帕金森综合征:一项初步综述。
Biomed Res Int. 2014;2014:371256. doi: 10.1155/2014/371256. Epub 2014 Aug 14.
7
The role of the Ala746Thr variant in the ATP13A2 gene among Chinese patients with Parkinson's disease.ATP13A2 基因 Ala746Thr 变异在中国帕金森病患者中的作用。
J Clin Neurosci. 2013 May;20(5):761-2. doi: 10.1016/j.jocn.2012.05.052. Epub 2013 Mar 20.